The estimated Net Worth of Nathan Lawrence is at least $81 dollars as of 19 December 2018. Nathan Lawrence owns over 1,000 units of Pressure BioSciences stock worth over $81 and over the last 18 years Nathan sold PBIO stock worth over $0.
Nathan has made over 5 trades of the Pressure BioSciences stock since 2006, according to the Form 4 filled with the SEC. Most recently Nathan bought 1,000 units of PBIO stock worth $2,000 on 19 December 2018.
The largest trade Nathan's ever made was buying 2,000 units of Pressure BioSciences stock on 19 July 2006 worth over $6,540. On average, Nathan trades about 175 units every 162 days since 2006. As of 19 December 2018 Nathan still owns at least 2,932 units of Pressure BioSciences stock.
You can see the complete history of Nathan Lawrence stock trades at the bottom of the page.
Nathan's mailing address filed with the SEC is 51 Belmont St #1, South Easton, MA 02375, USA.
Over the last 21 years, insiders at Pressure BioSciences have traded over $0 worth of Pressure BioSciences stock and bought 433,961 units worth $321,010 . The most active insiders traders include Gregory Gene Freitag, Richard T Schumacher a Kevin W Quinlan. On average, Pressure BioSciences executives and independent directors trade stock every 111 days with the average trade being worth of $342. The most recent stock trade was executed by Bradford Addison Young on 31 December 2018, trading 1,579 units of PBIO stock currently worth $3,553.
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the Americas, Europe, Asia, Africa, and Australia. Its pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. It serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. Pressure BioSciences, Inc. has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts.
Pressure BioSciences executives and other stock owners filed with the SEC include: